Home News

Professor Melitta Schachner to be awarded prestigious honorary degree

Dr. Melitta Schachner has been selected to receive a prestigious honorary doctorate degree from the University of Heidelberg—the first such honor for extraordinary achievement in the life sciences that the institution has awarded in 50 years.

In 1976, Schachner became the first chair of the Department of Neurobiology at Heidelberg, where she also led the development of the Center for Neuroscience. She later established a Center for the Study of Neurobiology at Swiss Federal Institute of Technology in Zurich.

A member of the German Academy of Sciences, Schachner has focused her research and written prolifically on the cellular and molecular mechanisms that underlie development, maintenance, and modifications of the adult central nervous system. She has authored more than 800 articles in peer-reviewed journals. In 1965, as a summer student at the California Institute of Technology, she studied with Max Delbrück, the last person to receive the honor that Schachner will receive in Heidelberg in November.

Congratulations, Dr. Schachner!


Dr. Ronald Hart directs bioinformatics core for $3.3M NIH epigenetics study

The National Center for Complementary & Integrative Health (NCCIH) of the National Institutes of Health has awarded Professor Ah-Ng Tony Kong, Distinguished Professor, Glaxo Endowed Chair in Pharmaceutics and Graduate Director, a 5-year RO1 grant of $3,335,313 for the project, “Epigenetic mechanisms of indole-3-carbinol (I3C)/diindolylemthane (DIM) and triterpenoids in prevention of prostate inflammation and related disease.” The I3C/DIM found abundantly in cruciferous vegetables and triterpenoid ursolic acid (UA) from medicinal plants, fruits and vegetables such as blueberries, cranberries, beets, and mushrooms, are commonly used as botanical dietary supplements.  This grant will examine how chronic inflammatory processes can drive changes of inflammatory epigenome and investigate how botanical/natural products can modify these inflammatory epigenomic alterations resulting in suppression of inflammation and its related diseases including cancer in the prostate. In addition, the Analytical Core directed by Drs. Ronald P. Hart (Cell Biology), Brian T. Buckley (EOHSI) and Michael Verzi (Genetics) will develop the latest technology in next-generation sequencing coupled with bioinformatics, and in vivo metabolism, pharmacokinetics-pharmacodynamics studies of botanicals using LCMS technology.  Better understanding of the molecular mechanism of I3C, DIM and UA via epigenetic alterations can enhance the use of I3C, DIM and UA in disease prevention and can potentially benefit thousands.

<Read the official announcement>

Dr. Mike Kiledjian, Chair and Distinguished Professor, is featured in SAS newsletter

Read about Dr. Kiledjian's journey to Rutgers

Congratulations to our Recently Promoted Professors

Two CBN professors were promoted on July 1st.  Mike Kiledjian, CBN Chair, was promoted to Distinguished Professor and Ping Xie was promoted to Associate Professor with tenure. 


Congratulations to the CBN Class of 2015!

We wish you success in all you do.

CBN Celebration 2015 rev